Key Questions on PARP Inhibitors in Ovarian Cancer: Experts Evaluate the Latest Evidence

Download All
In this interactive recording of a live CCO webinar, experts discuss the latest data on safely and effectively leveraging PARP inhibitors for treating patients with ovarian cancer. Download the slides for use in your own presentations!
Prof Jonathan A. Ledermann, MD, FRCP, FMed Sci
person default
Frederik Marmé, MD, PhD
Prof Isabelle Ray Coquard

On-Demand Webcast

Watch this on-demand webcast capturing a live CCO webinar to gain global perspectives on the latest data on safely and effectively leveraging PARP inhibitors for treating patients with ovarian cancer

Prof Jonathan A. Ledermann, MD, FRCP, FMed Sci person default Frederik Marmé, MD, PhD Prof Isabelle Ray Coquard Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: July 20, 2021 Expired: July 19, 2022

Downloadable Slidesets

Download this short summary slideset of key takeaway points from a live interactive discussion on the latest data on PARP inhibitors in the treatment of ovarian cancer.

Prof Jonathan A. Ledermann, MD, FRCP, FMed Sci person default Frederik Marmé, MD, PhD Prof Isabelle Ray Coquard Released: July 6, 2021

Download this slideset on the global experience of using PARPi in patients with ovarian cancer.

Prof Jonathan A. Ledermann, MD, FRCP, FMed Sci Released: July 1, 2021

Download this slideset on the management of PARPi related adverse events in patients with ovarian cancer.

Prof Jonathan A. Ledermann, MD, FRCP, FMed Sci Released: July 1, 2021

Download this slideset on potential of using PARP inhibitor monotherapy or in combination in patients with ovarian cancer.

Prof Isabelle Ray Coquard Released: July 1, 2021

Download this slideset on the use of PARP inhibitors in clinical practice in patients with ovarian cancer.

person default Frederik Marmé, MD, PhD Released: July 1, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
AstraZeneca

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue